Statistics

Total Visits

	Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple	801

File Visits

	Downloads
TFG-M-M1037.pdf	401
TFG-M-M1037-ANEXO.pdf	180

Select a period of time:

ViewsDownloads

Number of views in the range

	Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple	207

Number of downloads in the range

	Downloads
TFG-M-M1037.pdf	30
TFG-M-M1037-ANEXO.pdf	19

Views

	Views
October 2025	31
November 2025	48
December 2025	20
January 2026	44
February 2026	27
March 2026	35
April 2026	2

Download CSV file

Bar graph

Line graph

Number of downloads in the period of time

Downloads
October 2025

3
November 2025

10
December 2025

10
January 2026

9
February 2026

7
March 2026

8
April 2026

2
Download CSV file

Bar graph

Line graph

Top country views

	Views
United States	74
Spain	20
China	17
Brazil	14
Vietnam	8
Belgium	8
Germany	6
France	5
United Kingdom	5
Hong Kong	5

Top countries by downloads

	Downloads
United States	10
Spain	5
China	4
Hong Kong	2
United Kingdom	1
France	1

Top cities views

	Views
Los Angeles	7
Dallas	7
Central	5
Madrid	5
Brussels	5
Valladolid	4
São Paulo	3
Caracas	3
Ashburn	2
Boardman	2

Top cities by downloads

	Downloads
Los Angeles	3
Central	2
Madrid	1